help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuwahara, K.
Right arrow Articles by Watanabe, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuwahara, K.
Right arrow Articles by Watanabe, Y.
Related Collections
Right arrow Calcium and Bone Metabolism
Right arrow Endocrine Oncology
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 7 2408-2409
Copyright © 2007 by The Endocrine Society


IMAGE IN ENDOCRINOLOGY

Increased 18F-Fluorodeoxyglucose Uptake in a Brown Tumor in a Patient with Primary Hyperparathyroidism

Kazuhiro Kuwahara, Shoichiro Izawa, Hiroyuki Murabe, Norihiko Murakami, Toshihiko Yokota, Yoji Wani, Kenji Notohara, Choutatsu Tsukayama, Takayoshi Ishimori and Yuji Watanabe

Departments of Endocrinology and Rheumatology (K.K., S.I., H.M., N.M., T.Y.), Pathology (Y.Wan., K.N., C.T.), and Radiology (T.I., Y.Wat.), Kurashiki Central Hospital, Miwa, Kurashiki, Okayama 710-8602, Japan

Address all correspondence and requests for reprints to: Kazuhiro Kuwahara, 1-1-1 Miwa, Kurashiki, Okayama 712-8602, Japan. E-mail: kk10734{at}kchnet.or.jp.

A 35-year-old woman was admitted to our hospital with hip pain. She has no family history of primary hyperparathyroidism. Serum calcium, phosphate, creatinine, alkaline phosphatase, and intact PTH levels were 3.14 mmol/liter (range, 2.23–2.65), 0.55 mmol/liter (range, 0.74–1.49), 68.95 µmol/liter (range, 39.78–70.72), 5112 U/liter (range, 110–360), and 1100 pg/ml (range, 10–65), respectively. We found a 99mTc-hexakis 2-methoxy 2-methyl propyl isonitrile (MIBI) avid 18F-fluorodeoxyglucose (18F-FDG) negative posterior mediastinal tumor 7.0 cm in diameter. 18F-FDG positron emission tomography (PET)/computed tomography (CT) showed multiple 18F-FDG-avid osteolytic lesions (Fig. 1Go). Biopsy of the left iliac bone revealed an osteolytic lesion replaced by proliferating fibroblastic cells and multinucleated giant cells. At the periphery, osteoid formation and osteoblastic proliferation were observed. Resection of the mediastinal tumor was performed, and pathological diagnosis confirmed parathyroid adenoma. Six months later, 18F-FDG PET/CT showed sclerotic changes of bones with no focal 18F-FDG uptake (Fig. 2Go).


Figure 1
View larger version (63K):
[in this window]
[in a new window]

 
FIG. 1. FDG-PET/CT shows multiple enhanced 18F-FDG uptake in bones (A), particularly in the left iliac bone (maximum standardized uptake value is 12.5), and an osteolytic lesion in the left iliac bone (arrow) (B).

 

Figure 2
View larger version (57K):
[in this window]
[in a new window]

 
FIG. 2. FDG-PET/CT, 6 months after resection of parathyroid adenoma, showing drastic response to treatment (A) and osteoblastic changes in brown tumor (B).

 
Although increased 18F-FDG uptake in brown tumors has been reported (1), this is the first report to describe the clinical course and postoperative 18F-FDG PET/CT. Osteoclast-like giant cell-containing lesions, such as giant cell reparative granuloma, aneurysmal bone cyst, and giant cell tumor, show increased 18F-FDG uptake despite benign characteristics. Interestingly, many 18F-FDG-avid benign lesions can reportedly be categorized as giant cell- or histiocyte-containing lesions (2). These cells are in the monocyte-macrophage lineage, with energy predominantly supplied by intracellular glucose metabolism (3, 4). However, fibroblasts are also frequently observed within the lesions (5) and known to show a high accumulation of FDG. Further investigations are necessary to elucidate the mechanism of 18F-FDG accumulation in brown tumor.


    Footnotes
 
Disclosure Summary: The authors have nothing to disclose.

Abbreviations: CT, Computed tomography; 18F-FDG, 18F-fluorodeoxyglucose; PET, positron emission tomography.

Received March 15, 2007.

Accepted April 10, 2007.


    References
 Top
 References
 

  1. Michael S, Doris B, Berno H, Albrecht G, Erich H, Michael RS, Christoph GD, Alexandra V, Jörg K, Sven NR 2000 Grading of tumor and tumorlike lesions of bone: evaluation by FDG PET. J Nucl Med 41:1695–1701[Abstract/Free Full Text]
  2. Aoki J, Watanabe H, Shinozaki T, Takagishi K, Ishijima H, Oya N, Sato N, Inoue T, Endo K 2001 FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 219:774–777[Abstract/Free Full Text]
  3. Meszaros K, Lang CH, Bagby GJ, Spitzer JJ 1987 Contribution of different organs to increased glucose consumption after endotoxin administration. J Biol Chem 262:10965–10970[Abstract/Free Full Text]
  4. Gamelli RL, Liu H, He L, Hofmann CA 1996 Augmentation of glucose transporter-1 in macrophages following thermal injury and sepsis in mice. J Leukoc Biol 59:639–647[Abstract]
  5. Dahlin DC, Unni KK 1986 Bone tumors: general aspects and data on 8,542 cases. Conditions that commonly simulate primary neoplasms of bone. Chap 28. 4th ed. Springfield, IL: Charles Thomas; 413–421




This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuwahara, K.
Right arrow Articles by Watanabe, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuwahara, K.
Right arrow Articles by Watanabe, Y.
Related Collections
Right arrow Calcium and Bone Metabolism
Right arrow Endocrine Oncology


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals